DIA 2019 Global Annual Meeting

PRA Health Sciences and Jumo Health embarked on an ambitious effort to ensure all pediatric studies are designed with children in mind from the beginning of the study design. PRA's Center for Pediatric and Vaccine Clinical Development (CPCVD) is the focal point and repository for PRA’s global pediatrics knowledge. We understand development of treatments for the pediatric population is complex and requires a multi-faceted approach to address the inherent challenges of conducting clinical trials in children. Jumo Health develops age¬ appropriate, educational resources for patients and caregivers for use throughout their medical journey. With the belief that an informed patient is a capable patient, Jumo Health designs its solutions for outcomes. Studies may require many years of follow-up that may continue from infancy to adulthood. This timeline presents issues of evolving assent; providing progressively more complex information to patients and caregivers; the transition to adulthood and consent; and the challenges of ensuring data privacy. The CPVCD has expertise with each of these complexities. With experience in more than 50 countries, covering more than 200 topics, Jumo’s mixed media solutions range from comic books to animated and live action videos, activity and appreciation items, and much more. During this session PRA’s Center for Pediatric and Vaccine Clinical Development and Jumo Health will highlight how focused and age specific recruitment and retention tools have an impact on results.